Sökning: "Brain tumors"
Visar resultat 21 - 25 av 167 avhandlingar innehållade orden Brain tumors.
21. Immuno Gene Therapy of Rat Brain Tumors with interferon-gamma transfected glioma cells
Sammanfattning : Immunotherapy is a new promising approach in cancer treatment. In the future, it will hopefully offer an alternative to existing brain tumors treatments, which are unable to cure. We have established an experimental, low immunogenic, brain tumor model in the rat. LÄS MER
22. Immunotherapy against malignant brain tumors - of mice and men
Sammanfattning : Glioblastoma Multiforme (GBM) is the most abundant and most aggressive primary brain tumor in adults. Due to the infiltrative growth of the tumor, surgery will never be radical. Radiation and chemotherapy only marginally improve the poor prognosis due to the ability of the GBM to develop resistance towards these treatments. LÄS MER
23. Beyond Survival - Cognition after Pediatric Brain Tumor
Sammanfattning : Background: Pediatric Brain Tumor (PBT) survivors suffer from cognitive sequelae, especially within the areas of cognitive tempo, attention, executive function and memory. The cognitive difficulties are often accentuated over the years, but knowledge about the long term trajectory is still scarce. LÄS MER
24. Gene expression studies in human astrocytoma, with emphasis on oncostatin M induced effects
Sammanfattning : Brain tumors comprise about one percent of all cancers and astrocytoma is the most common primary brain malignancy. According to the World Health Organization system, the astrocytomas are divided into four grades according to degree of malignancy. Grade I, pilocytic astrocytoma (PA), is the least malignant form and most often affects children. LÄS MER
25. Multivariate analyses of proteomic and metabolomic patterns in brain tumors
Sammanfattning : Glioblastoma multiforme (GBM) is the most common primary brain tumor. Given the current standard of care, the prognosis for patients diagnosed with this disease is still poor. There consequently exists a need to improve current treatments, as well as to develop new ones. LÄS MER